Ibritumomab: The Detailed Examination into This Specific Tumour Treatment
Ibritumomab, sometimes referred to as Zevalin, represents a novel form of specific radiotherapy applied to combat certain kinds of non-Hodgkin's lymphoma , particularly previously treated lymphomas. This is a monoclonal antibody conjugated to Y-90 , the radioactive element that releases precise r